MetaCap

Connect Biopharma Insider Trades

NASDAQ: CNTBHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.59-0.0382 (-6.08%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
2 · $4.37M
Sales
0 · $0
Shares bought / sold
1.31M / 0
Net activity
Net buying $4.4 million

Connect Biopharma insider activity

Over the last 12 months, Connect Biopharma insiders reported 8 transactions on SEC Form 4: 2 open-market purchases and 0 sales. Insiders bought $4.4 million and sold $0 worth of stock, for net insider buying of $4.4 million. The most recent filing shows LIU JEAN I (Director) reporting a transaction in 8,984 shares on Sep 30, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CNTB's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

CNTB insider transactions

Connect Biopharma insider transactions
DateInsiderTypeSharesValueFiling
Sep 30, 2026Xanthopoulos Kleanthis GabrielDirectorAward5,000—Form 4
Sep 30, 2026LIU JEAN IDirectorAward8,984—Form 4
Jun 30, 2026LIU JEAN IDirectorAward6,718—Form 4
Jun 30, 2026Xanthopoulos Kleanthis GabrielDirectorAward3,738—Form 4
May 29, 2026Huang JamesDirectorBuy150,000$371.61KForm 4
Mar 31, 2026Huang JamesDirectorBuy1,160,000$4.00MForm 4
Mar 31, 2026LIU JEAN IDirectorAward5,061—Form 4
Mar 31, 2026Xanthopoulos Kleanthis GabrielDirectorAward2,816—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related